Sector consensus Virax Biolabs Group Limited

Equities

Real-time Estimate Cboe BZX Other stock markets 18:07:25 21/01/2026 GMT			5-day change	1st Jan Change
0.2630 ^USD	-8.04%		-22.57%	-25.39%

12-02	Virax Biolabs Group Limited announced that it expects to receive $5 million in funding	CI
12-02	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
VIRAX BIOLABS GROUP LIMITED	-	-	US$1	+249.65%	1
LONZA GROUP AG			CHF 677.74	+24.68%	23
IQVIA HOLDINGS INC.			US$259.65	+11.11%	20
BEONE MEDICINES AG			US$404.19	+20.91%	24
CELLTRION, INC.			₩235,751.77	+13.89%	22
REVOLUTION MEDICINES, INC.			US$100.79	-13.28%	19
MEDPACE HOLDINGS, INC.			US$545.75	-9.4%	12
EUROFINS SCIENTIFIC SE			€67.85	-3.56%	15
ICON PUBLIC LIMITED COMPANY			US$205.69	+16.49%	16
ASCENDIS PHARMA A/S			US$230.53	+25.47%	15
TEMPUS AI, INC.			US$87.92	+31.65%	12
IONIS PHARMACEUTICALS, INC.			US$90.63	+16.89%	22
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			US$213.21	-2.28%	14
BIO-TECHNE CORPORATION			US$70	+0.63%	12
QIAGEN N.V.			US$52.87	-4.65%	13
Average			15,917.31	+25.21%	16
Weighted average by Cap.			24,875.97	+11.57%	19